HC Wainwright Reiterates Buy Rating for Transcat (NASDAQ:TRNS)

Transcat (NASDAQ:TRNS)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report released on Friday,Benzinga reports. They presently have a $116.00 price target on the scientific and technical instruments company’s stock. HC Wainwright’s price objective suggests a potential upside of 28.28% from the company’s previous close. HC Wainwright also issued estimates for Transcat’s FY2027 earnings at $2.45 EPS.

A number of other brokerages have also issued reports on TRNS. Lake Street Capital began coverage on Transcat in a research note on Thursday, July 10th. They set a “buy” rating and a $105.00 price target for the company. Wall Street Zen raised Transcat from a “sell” rating to a “hold” rating in a research note on Wednesday, May 28th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Transcat presently has a consensus rating of “Moderate Buy” and an average target price of $112.20.

Transcat Stock Performance

Shares of TRNS stock opened at $90.43 on Friday. Transcat has a 12-month low of $67.56 and a 12-month high of $133.72. The firm has a market capitalization of $842.81 million, a price-to-earnings ratio of 63.24 and a beta of 0.71. The business has a 50 day simple moving average of $82.82 and a 200 day simple moving average of $80.67. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.92 and a quick ratio of 2.36.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.19. Transcat had a return on equity of 6.66% and a net margin of 4.64%.The business had revenue of $76.42 million during the quarter, compared to analyst estimates of $72.28 million. On average, equities research analysts anticipate that Transcat will post 2.3 EPS for the current year.

Institutional Investors Weigh In On Transcat

Several large investors have recently modified their holdings of the stock. Centiva Capital LP boosted its stake in shares of Transcat by 6.0% during the 4th quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company’s stock worth $318,000 after acquiring an additional 171 shares in the last quarter. White Pine Capital LLC boosted its stake in shares of Transcat by 1.7% during the 2nd quarter. White Pine Capital LLC now owns 10,175 shares of the scientific and technical instruments company’s stock worth $875,000 after acquiring an additional 171 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Transcat by 0.6% during the 1st quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company’s stock worth $2,078,000 after acquiring an additional 172 shares in the last quarter. Arkadios Wealth Advisors boosted its stake in shares of Transcat by 3.3% during the 2nd quarter. Arkadios Wealth Advisors now owns 5,814 shares of the scientific and technical instruments company’s stock worth $500,000 after acquiring an additional 187 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Transcat by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company’s stock worth $543,000 after acquiring an additional 194 shares in the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.